Mover and shaker

MassChallenge Texas names former Houston Exponential leader as local exec

Jon Nordby, former exec at Houston Exponential, will lead the inaugural Houston MassChallenge cohort. Courtesy of MassChallenge

MassChallenge Texas in Houston, a zero-equity startup accelerator, has named its managing director. Jon Nordby, who recently served as Houston Exponential's director of strategy since its launch, will lead the organization's inaugural cohort.

"MassChallenge's not-for-profit, no equity model is uniquely suited to accelerate the development of Houston's innovation ecosystem and is the foundation early-stage startups need to get to the point of disruption or pivot as fast as possible," says Nordby in a release.

Before HX, Nordby served as vice president of talent and innovation at the Greater Houston Partnership, and was essential in creating the organization's Innovation Initiative.

"I was thrilled when MassChallenge established their first Texas office in 2017 and I'm excited to bring my experience leading Houston ecosystem efforts to attract founders from around the world and connect them with everything this city can offer, help them establish roots, and forge the partnerships they need for success," Nordby continues.

MassChallenge's first Houston cohort, which will accelerate 25 startups, begins in July. Applications are open until Friday, May 10, at noon.

The organization, which has locations around the world, looks for early stage startups that haven't raised more than $500,000 in equity-based funding and have generated less than $1 million in revenue over the past year. The selected startups will receive free GreenStreet office space, mentorship, investment opportunities, and more.

Also new to the team is Lauren Mitchell, who will serve as the local chapter's community manager. A native Houstonian, Mitchell comes from leading marketing and partnerships at Discovery Green. Yvette Casares Willis, who oversees statewide partnerships for the organization, is also based in Houston.

"MassChallenge Texas is providing innovation at scale in programs in Austin and Houston by connecting startups to resources throughout this great state," says Mike Millard, managing director of MassChallenge Texas, in the release. "The addition of Jon to our team will accelerate our pace in the state and advance our mission by connecting startups to deep industry resources and expertise that are available to startups in Houston."

Trending News

Building Houston

 
 

Houston-based Melax Tech has developed multiple Natural language processing tools that are used by more than 650 health care and life science organizations. Photo via MelaxTech.com

Melax Tech Partners, a leader in natural language technology processing, announced a new partnership with the University of California at Irvine that will help researchers derive insights from the UCI Health Data Science Platform’s electronic health records system and improve patient care.

Melax will implement its signature text annotation tool LANN to pull information from clinical notes, and its CLAMP product to develop natural language processing customizations through the use of AI, according to a statement from the company.

“There has been a strong desire among UCI researchers to have the capability to analyze free-text clinical narrative data using cutting-edge NLP technologies," Kai Zheng, chief research information officer at UCI Health Affairs, says in a statement. "We are delighted to have this opportunity to work with Melax Tech to deploy their AI-driven annotation and analytics tools to help our researchers advance their research agenda by leveraging the vast amount of free-text data that our health system has accumulated in the past two decades.”

Natural language processing, or NLP, allows organizations and healthcare groups to sift through and analyze massive amounts of data at a rapid rate through the use of machine learning and AI. Houston-based Melax Tech, founded in 2017, has developed multiple NLP tools that are used by more than 650 health care and life science organizations, according to its website.

In addition to the recent partnership with UC Irvine, Melax has also recently partnered with Vanderbilt University Medical Center and the University of Western Pennsylvania on similar clinical projects.

Melax has also used its platforms to pull vital information from datasets relating to COVID-19, in both medical and social settings.

In March 2022, it was awarded a Phase 1 NIH Award, valued at $300,000, to develop informatics tools based on COVID-19 datasets with the San Diego Supercomputer Center at UC San Diego. The tool aims to help researchers better understand vast amounts of virus-related data and connect findings with other similar results.

In August, Melax also received another $300,000 grant from the National Institute of Allergy and Infectious Diseases to develop NLP-based algorithms that will "model, extract and synthesize vaccine misinformation from multiple popular social media sources," according to a statement. Melax will also develop a visualization that presents its findings on the misinformation into a compressible format.

"This is a very real topic affecting culture at present," Andre Pontin, CEO at Melax Tech, says in a statement. "And shows that we as a collective business and group of experts continue to be on the cutting-edge of science in the NLP and AI domain."

Trending News